v3.26.1
Consolidated Statements of Cash Flows
 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Cash flows from Operating Activities    
Net loss $ (36,611,668) $ (57,687,289)
Adjustment to reconcile net loss to cash used in operating activities:    
Change in fair value of earn-out liabilities (630,000) (40,000)
Change in fair value of warrant liabilities (8,955,750) 56,000
Share-based compensation 10,774,457 20,723,153
Amortization of step-up in loans held for investment 169,607 732,393
Provision for credit losses on loans held for investment 1,014,811 1,052,651
Origination of loans and leases for resale (33,625,191) (27,023,006)
Proceeds from sale of loans and leases for resale 38,108,690 31,025,468
Gain on sale of loans and leases (4,483,499) (4,002,463)
Impairment of lease merchandise 466,038 0
Impairment of software capitalization 3,596,002 0
Depreciation and amortization 6,614,582 3,258,810
Non-cash operating lease expense 257,657 377,176
Changes in operating assets and liabilities:    
Accounts receivable (1,255,540) (242,940)
Lease receivable (156,516) 0
Interest receivable 63,654 (314,104)
Inventory (1,806) (1,224,215)
Prepaid expenses and other current assets 534,447 1,519,271
Deposits (8,178) 13,542
Accounts payable 2,705,852 (1,737,159)
Accrued expenses 393,087 (62,346)
Deferred revenue 1,348,451 (171,477)
Operating lease liabilities (260,585) (382,186)
Net cash used in operating activities (19,941,398) (34,128,721)
Cash flows from Investing Activities    
Additions to lease merchandise, net of disposals (3,337,606) 0
Software development costs (2,893,739) (3,681,123)
Principal paydowns on loans held for investment 18,838,335 13,456,408
Disbursements for loans held for investment (22,638,542) (12,935,888)
Acquisition of businesses, net of cash acquired 0 141,215
Net cash used in investing activities (10,486,552) (3,019,388)
Cash flows from Financing Activities    
Proceeds from convertible note payable, related party (Note 12) 0 20,000,000
Net disbursements for taxes paid related to vesting of employee restricted stock units 0 (468,981)
Proceeds from issuances of common stock and pre-funded warrants, net 6,720,667 0
Proceeds from issuances of common stock, net of issuance costs 1,203,244 39,299,795
Proceeds from revolving line of credit 11,921,744 7,018,052
Repayments on revolving line of credit (9,524,477) (8,557,180)
Cash paid for stock issuance costs (365,516) 0
Net cash provided by financing activities 9,955,662 57,291,686
Net (decrease) increase in cash, cash equivalents and restricted cash (20,472,288) 20,143,577
Cash, cash equivalents, and restricted cash, beginning of period 36,589,607 16,446,030
Cash, cash equivalents, and restricted cash, end of the period 16,117,319 36,589,607
Cash and cash equivalents from continuing operations 14,644,384 35,727,694
Restricted cash from continuing operations 1,119,580 265,253
Cash and cash equivalents from discontinued operations 353,355 596,660
Total cash, cash equivalents, and restricted cash, end of the period 16,117,319 36,589,607
Supplemental Cash Flow Information    
Cash paid for interest for convertible notes and revolving line of credit 3,509,485 2,302,697
Supplemental disclosure of noncash investing and financing activities:    
Issuance of common shares in connection with the asset acquisition 4,500,000 0
Earnout liability generated by asset acquisition 550,000 0
Operating lease right-of-use asset obtained in exchange for operating lease liability 652,410 0
Accrued variable compensation settled with RSU grants 597,397 411,878
Shares issued in connection with Credova Merger 0 14,137,606
Note Exchange in connection with Credova Merger 0 8,449,500
License    
Cash flows from Investing Activities    
Purchase of licenses $ (455,000) $ 0